The SOTPA group was initiated in early 2013 following recognition that pharmacists working within solid
organ transplantation needed a platform to promote networking, education and professional development.
It was also recognized that a national Solid Organ Transplant Group would have been beneficial during
the preservation solution crisis; this has led to the Group responding to other current challenges within transplant pharmacy, notably the introduction of generics and the move of immunosuppressant
prescribing to secondary care.
We have recently had confirmation with affiliation to the Royal Pharmaceutical Society and The British Transplant Society.